Literature DB >> 16193476

New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.

Stephan Klebe1, Alexandra Durr, Alexander Rentschler, Valerie Hahn-Barma, Michael Abele, Naima Bouslam, Ludger Schöls, Pierre Jedynak, Sylvie Forlani, Elodie Denis, Christel Dussert, Yves Agid, Peter Bauer, Christoph Globas, Ullrich Wüllner, Alexis Brice, Olaf Riess, Giovanni Stevanin.   

Abstract

Autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurological disorders. Point mutations in the gene encoding protein kinase Cgamma (PRKCG) are responsible for spinocerebellar ataxia 14 (SCA14). We screened for mutations in the PRKCG gene, in a large series of 284 ADCA index cases, mostly French (n=204) and German (n=48), in whom CAG repeat expansions in the known SCA genes were previously excluded. Six mutations were found that segregated with the disease and were not detected on 560 control chromosomes, including F643L (exon 18), already reported in another French kindred. Five new missense mutations were identified in exons 4 (C114Y/G123R/G123E), 10 (G360S) and 18 (V692G). All but one (V692G) were located in highly conserved regions of the regulatory or catalytic domains of the protein. All six SCA14 families were French and there was no evidence of reduced penetrance. The phenotype consisted in a very slowly progressive cerebellar ataxia with a mean age at onset of 33.5+/-14.2 years (range 15 to 60 years), occasionally associated with executive dysfunction, myoclonus, myorythmia, tremor or decreased vibration sense. SCA14 represented only 1.5% (7/454) of French ADCA families but none of the German families. It should, however, be considered in patients with slowly progressive ADCA, particularly when myoclonus and cognitive impairment are present.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193476     DOI: 10.1002/ana.20628

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

1.  Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.

Authors:  Huading Lu; Lei Zhu; Liyi Lian; Mingwei Chen; Dehai Shi; Kun Wang
Journal:  Tumour Biol       Date:  2015-02-09

2.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Authors:  Sarah Doss; Jan Leo Rinnenthal; Tanja Schmitz-Hübsch; Alexander U Brandt; Sebastian Papazoglou; Silke Lux; Stephan Maul; Jens Würfel; Matthias Endres; Thomas Klockgether; Martina Minnerop; Friedemann Paul
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

4.  A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Authors:  Katherine E Hekman; Guo-Yun Yu; Christopher D Brown; Haipeng Zhu; Xiaofei Du; Kristina Gervin; Dag Erik Undlien; April Peterson; Giovanni Stevanin; H Brent Clark; Stefan M Pulst; Thomas D Bird; Kevin P White; Christopher M Gomez
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

5.  A novel mutation in the C2 domain of protein kinase C gamma associated with spinocerebellar ataxia type 14.

Authors:  Takehiro Ueda; Tsuneyoshi Seki; Kimitaka Katanazaka; Kenji Sekiguchi; Kazuhiro Kobayashi; Fumio Kanda; Tatsushi Toda
Journal:  J Neurol       Date:  2013-04-21       Impact factor: 4.849

Review 6.  Vertical supranuclear gaze palsy in Niemann-Pick type C disease.

Authors:  Ettore Salsano; Chizoba Umeh; Alessandra Rufa; Davide Pareyson; David S Zee
Journal:  Neurol Sci       Date:  2012-07-19       Impact factor: 3.307

Review 7.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

8.  Protection from ataxia-linked apoptosis by gap junction inhibitors.

Authors:  Dingbo Lin; Dolores J Takemoto
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

9.  Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse.

Authors:  Yunong Zhang; Adam Snider; Lloyd Willard; Dolores J Takemoto; Dingbo Lin
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

10.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.